Meal timing and water intake with Zenagamtide for overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (male or female, any gender identity).
- You have overweight or obesity (based on your BMI).
- You do not have diabetes (based on a blood test at screening).
- You do not have any significant stomach or gut problems that could affect how the medicine is absorbed.
- You do not have unusual eating habits or follow a special diet that would interfere with the study meal schedule.
- You are not allergic to the study medicine or related products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.
This study tests how well adults with overweight or obesity, with or without type 2 diabetes, tolerate switching from their current weight-loss medication (tirzepatide) to a new medicine called zenagamtide. It may help you understand if this new option is easier on your stomach.
This study tests an investigational weight-loss medicine called Zenagamtide for people who have heart or blood vessel disease and are overweight or obese. The goal is to see if it can reduce heart-related risks compared to a placebo (a pill with no active medicine).
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
This study tests a new medicine called zenagamtide for adults with overweight or obesity, with or without type 2 diabetes, who are currently taking semaglutide. The goal is to see how well people tolerate switching from semaglutide to the new treatment.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.